By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Acacialaan 7

Leiderdorp    2351 CA  The Netherlands
Phone: 31-0-621628475 Fax:



Start Up

Company News
The Medicines Company (MDCO) Announces Positive Phase III Trial Results for Fibrocaps; Completes ProFibrix Acquisition 8/6/2013 6:49:25 AM
The Medicines Company (MDCO) Signs Agreement to Acquire ProFibrix for Up to $10 Million 6/4/2013 6:50:39 AM
ProFibrix Completes Patient Enrolment in Pivotal Phase III With Fibrocaps™ and Reports Positive Feedback From Surgical Community 4/4/2013 11:43:38 AM
ProFibrix Passes Halfway Mark of Patient Enrolment in Pivotal Phase 3 With Fibrocaps™ and Successfully Concludes Safety Review Assessment 11/8/2012 10:21:43 AM
ProFibrix to Present FibrocapsTM Phase II Data & Progress in Recombinant Fibrinogen Program at International Conferences 7/5/2012 10:54:59 AM
ProFibrix US Phase II Study with FibrocapsTM Meets All Primary and Secondary Endpoints 1/5/2012 6:16:37 AM
ProFibrix Phase II with FibrocapsTM Meets Primary Endpoint – On Track for Phase III in 2012 11/15/2011 6:18:44 AM
ProFibrix Completes Enrollment of Phase II Studies with Lead Hemostasis Product FibrocapsTM and Targets Start of Phase III in H1 2012 9/13/2011 10:18:25 AM
ProFibrix Raises $22M to Progress Fibrocaps Topical Sealant into Phase III 5/4/2011 8:29:10 AM
ProFibrix Reports Phase II Results of Hemostasis Product Fibrocaps(TM) and Appoints New Chief Medical Officer 3/11/2010 8:21:09 AM